Circadian Clock and Beta Cell Stress Adaptation
昼夜节律时钟和β细胞应激适应
基本信息
- 批准号:8629855
- 负责人:
- 金额:$ 34.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-02-01 至 2019-01-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressApoptoticBeta CellBiological PreservationCell physiologyCellsCellular StressCircadian RhythmsCouplingDataDiabetes MellitusDietDoseFailureFastingFunctional disorderGene TargetingGenesGeneticGlucoseGoalsHomeostasisHumanImpairmentInsulinInterventionKnockout MiceKnowledgeLeadLife StyleLigandsLightLinkMediatingMetabolicMetabolic syndromeModelingMolecularMolecular TargetMusNutrientObese MicePathogenesisPathway interactionsPeriodicityPeripheralPhasePhenocopyPhysiologicalPlasmaPreventionProcessProductionProteinsRegimenRegulationRoleSecondary toSignal TransductionStimulusStressStress TestsTamoxifenTestingTranscriptional RegulationUp-Regulationarmbiological adaptation to stresscircadian pacemakercombatdiabeticdiabetic patientendoplasmic reticulum stressfeedingin vivoinsightinsulin secretionisletloss of functionmitochondrial dysfunctionnovelpreventpublic health relevanceresearch studyresponseshift worksimulationtranscription factor
项目摘要
DESCRIPTION (provided by applicant): Circadian disruption, the bane of modern lifestyle, has been strongly associated with diabetes and metabolic syndrome. Recent human studies also implicate b-cell dysfunction as a significant component of the metabolic abnormalities. It is,
therefore, imperative to understand the interaction between the circadian clock and regulation of ?-cell function for the preservation of insulin secretion to prevent diabetes. We have shown previously that genetic disruption of the circadian clock, by deletion of Bmal1, a non-redundant core clock gene, in mice, leads to ?-cell failure and diabetes, secondary to impaired glucose-stimulated ATP production, uncoupling of OXPHOS and impaired glucose-stimulated insulin secretion (GSIS). However, whether the intrinsic ?-cell clock is required for adaptive stress responses in ?-cells is unknown. In preliminary studies, we demonstrate that central clock disruption induced by shift work simulation, phenocopies genetic disruption of Bmal1 in ¿-cells in inducing Unfolded Protein Response (UPR), upregulation of the pro-apoptotic gene CHOP, suggestive of irremediable ER stress in ¿-cells, and is accompanied by impaired GSIS. Importantly, mice with a deletion of Bmal1 in ¿-cells become diabetic due to ¿-cell failure. Surprisingly, deletion of Rev-erb¿, a negative regulator of clock function and a Bmal1 target gene, leads to similar induction of unfolded protein response (UPR) in ¿-cells. We also show that ATF4, a key transcription factor involved in UPR, displays circadian rhythmicity in expression and is a direct transcriptional target of Bmal1. We, hence, hypothesized that intrinsic ?-cell clock regulators, Bmal1 and Rev-erb¿, coordinate the adaptive UPR pathway, through transcriptional control of its key components, to mitigate ER stress. The broad goal is to delineate key circadian clock-regulated pathways in ER stress-induced ¿-cell dysfunction through genetic, environmental and pharmacological modulation of the molecular clock. We will specifically 1. Test if circadian disruption is sufficient to induce ER stress and ¿-cell failure b dissecting the differential role of the central and peripheral clocks on ER stress and ¿-cell function. We will also determine the cell-autonomous role of the molecular clock in ER stress in ¿-cells 2. Define the transcriptional targets of Bmal1 and Rev-erb¿ in UPR and ER stress in ?-cells and 3. Test if the circadian clock regulates ER stress adaptive responses and insulin secretory response in human islets. We will also test if pharmacological modulation of the molecular clock can rescue adaptive stress signaling in diabetic patient islets. Collectively, the proposed studies will critically address how the molecular clock regulates ER stress and ¿-cell homeostasis and will lead to novel insights into circadian clock regulated adaptive stress pathways in ¿-cells. We envision that the results from this study will lead to discovery of targeted therapies to modulate circadian clock function for the preservation of ¿-cell function in combating diabetes.
描述(由申请人提供):昼夜节律紊乱是现代生活方式的祸根,与糖尿病和代谢综合征密切相关。最近的人体研究也暗示b细胞功能障碍是代谢异常的重要组成部分。它是什么,
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vijay K Yechoor其他文献
Circadian Desynchronization And Metabolic Stress Drive Heart Failure With Preserved Ejection Fraction (HFpEF)
昼夜节律失调和代谢应激驱动射血分数保留的心力衰竭(HFpEF)
- DOI:
10.1016/j.cardfail.2024.10.188 - 发表时间:
2025-01-01 - 期刊:
- 影响因子:8.200
- 作者:
Varun Mandi;Jeongkyung Lee;Rajaganapathi Jagannathan;Ping Yang;Joseph Danvers;Vinny Negi;Amit Kumar;Mohamad Rahmdel;Feng Li;Yijen Wu;Dhivyaa Rajasundaram;Vijay K Yechoor;Mousumi Moulik - 通讯作者:
Mousumi Moulik
Vijay K Yechoor的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vijay K Yechoor', 18)}}的其他基金
Circadian disruption-induced mitochondrial dysfunction in diabetes
昼夜节律紊乱引起的糖尿病线粒体功能障碍
- 批准号:
10317856 - 财政年份:2021
- 资助金额:
$ 34.57万 - 项目类别:
Circadian disruption-induced mitochondrial dysfunction in diabetes
昼夜节律紊乱引起的糖尿病线粒体功能障碍
- 批准号:
10673967 - 财政年份:2021
- 资助金额:
$ 34.57万 - 项目类别:
Tead1 - A Regulator of Quiescence and Proliferation in Pancreatic Beta Cells
Tead1 - 胰腺β细胞静止和增殖的调节因子
- 批准号:
10020885 - 财政年份:2016
- 资助金额:
$ 34.57万 - 项目类别:
Tead1 - A Regulator of Quiescence and Proliferation in Pancreatic Beta Cells
Tead1 - 胰腺β细胞静止和增殖的调节因子
- 批准号:
9032737 - 财政年份:2016
- 资助金额:
$ 34.57万 - 项目类别:
Tead1 - A Regulator of Quiescence and Proliferation in Pancreatic Beta Cells
Tead1 - 胰腺β细胞静止和增殖的调节因子
- 批准号:
9215521 - 财政年份:2016
- 资助金额:
$ 34.57万 - 项目类别:
Novel Regulators of Beta Cell Proliferation and Function
β细胞增殖和功能的新型调节剂
- 批准号:
10257754 - 财政年份:2016
- 资助金额:
$ 34.57万 - 项目类别:
Novel Regulators of Beta Cell Proliferation and Function
β细胞增殖和功能的新型调节剂
- 批准号:
10513301 - 财政年份:2016
- 资助金额:
$ 34.57万 - 项目类别:
Circadian Clock and Beta Cell Stress Adaptation
昼夜节律时钟和β细胞应激适应
- 批准号:
9010952 - 财政年份:2014
- 资助金额:
$ 34.57万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 34.57万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 34.57万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 34.57万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 34.57万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 34.57万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 34.57万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 34.57万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 34.57万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 34.57万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 34.57万 - 项目类别:
Research Grant